NSD2 serves as a potential prognostic biomarker in mantle cell lymphoma. Zhu Y, Ouyang B, Wang X, Wang X, et al. Lab Invest 2025 Apr 28:104181. doi: 10.1016/j.labinv.2025.104181.

Read + Share

Amedeo Smart

Independent Medical Education

Zhu Y, Ouyang B, Wang X, Wang X, et al. NSD2 serves as a potential prognostic biomarker in mantle cell lymphoma. Lab Invest 2025 Apr 28:104181. doi: 10.1016/j.labinv.2025.104181.
PMID: 40306573